Single-agent docetaxel (TXT) as first-line treatment in metastatic breast cancer (MBC)

被引:0
|
作者
Guarneri, D. [1 ]
Ratti, R. [1 ]
Venturino, A. [1 ]
Addamo, G. [1 ]
Coccorullo, Z. [1 ]
Colloca, G. [1 ]
Campora, E. [1 ]
机构
[1] Hosp Sanremo, San Remo, IM, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
11515
引用
收藏
页数:2
相关论文
共 50 条
  • [41] First-line single-agent cetuximab in patients with advanced colorectal cancer
    Pessino, A.
    Artale, S.
    Sciallero, S.
    Guglielmi, A.
    Fornarini, G.
    Andreotti, I. C.
    Mammoliti, S.
    Comandini, D.
    Caprioni, F.
    Bennicelli, E.
    Andretta, V.
    Siena, S.
    Sobrero, A.
    ANNALS OF ONCOLOGY, 2008, 19 (04) : 711 - 716
  • [42] First-line single-agent chemotherapy for patients with recurrent or metastatic gastric cancer with poor performance status
    Hwang, Jun-Eul
    Kim, Ha-Na
    Kim, Dae-Eun
    Shim, Hyun-Jeong
    Bae, Woo-Kyun
    Hwang, Eu-Chang
    Cho, Sang-Hee
    Chung, Ik-Joo
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2012, 4 (04) : 562 - 568
  • [43] Bevacizumab in first-line treatment of metastatic breast cancer
    Miles, David
    DRUGS, 2007, 67 (12) : 1800 - 1800
  • [44] BevacizumabIn First-Line Treatment of Metastatic Breast Cancer
    Lesley J. Scott
    Drugs, 2007, 67 : 1793 - 1799
  • [45] Single-agent gemcitabine as second- and third-line treatment in metastatic breast cancer
    Brodowicz, T
    Kostler, WJ
    Möslinger, R
    Tomek, S
    Vaclavik, I
    Herscovici, V
    Wiltschke, C
    Steger, GG
    Wein, W
    Seifert, M
    Kubista, E
    Zielinski, CC
    BREAST, 2000, 9 (06): : 338 - 342
  • [46] Bevacizumab in the first-line treatment of metastatic breast cancer
    Cameron, David
    EJC SUPPLEMENTS, 2008, 6 (06): : 21 - 28
  • [47] Continuing single-agent capecitabin as maintenance therapy after induction of XELOX (or FOLFOX) in first-line treatment of metastatic colorectal cancer
    Xu, Rui-hua
    Li, Yu-hong
    Luo, Huiyan
    Wang, Wei
    Wang, Zhiqiang
    Yuan, Xia
    Wang, Fenghua
    Zhang, Dong-sheng
    Ma, Dong
    Lin, Da Ren
    Jia, Jun
    Hu, Xiao-hua
    Peng, Jie Wen
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [48] First-line chemotherapy of advanced or metastatic breast cancer (MBC) with docetaxel and doxorubicin in Indonesia: results from A phase II trial
    Abdulmuthalib
    Darwis, Idral
    Prayogo, Nugroho
    Sutjipto
    MEDICAL JOURNAL OF INDONESIA, 2005, 14 (01) : 20 - 25
  • [49] Pharmacokinetic (PK) interaction between epidoxorubicin (EPI) and docetaxel (TXT) in patients with metastatic breast cancer (MBC)
    Cattel, L
    Airoldi, M
    Brusa, P
    Tagini, V
    Recalenda, V
    Marchionatti, S
    Bumma, C
    Pedani, F
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S328 - S328
  • [50] Safety and efficacy of first-line docetaxel-gemcitabine in metastatic breast cancer
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 168 - 168